Cartesian Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.43

+0.28 (+4.55%)

As of Apr 1, 2:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 80%

Hold 3 20%

Sell 0 0%

Price Target

Analyst Price Target +532.3% upside

Low Target $22.44

Average Target $40.66

High Target $45.57

Current Price $6.43

Current
$6.43

Target
$40.66

$22.44 $40.66 avg $45.57

Scenario Analysis

Bear Case

$22.44

249.0%

Low target

Base Case

$40.66

+532.3%

Avg target

Bull Case

$45.57

+608.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$15.96

-59.7% from high

52-Week Low

$5.98

+7.5% from low

Target vs 52W High

$40.66

+154.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%